drugset / Trial / NCT07712718

A Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379

NCT07712718 ↗

Phase 1 Recruiting 8 enrolled Mirum Pharmaceuticals, Inc.
NaSingle-groupOpen-labelBasic science

Summary

This is a Phase 1, open label study in healthy male participants to study the Absorption, Distribution, Metabolism, and Excretion of \[14C\]-MRM-3379 drug following a single oral dose.

Timeline

Start
2026-05-29
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MRM-3379 Unknown 5 mg Oral

Indications

No indication recorded.